MILTON, Ontario (AP) _ Aralez Pharmaceuticals Inc. (ARLZ) on Thursday reported a loss of $24.4 million in its third quarter.
The Milton, Ontario-based company said it had a loss of 37 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.
The specialty pharmaceutical company posted revenue of $24.3 million in the period.
Aralez Pharmaceuticals expects full-year revenue in the range of $95 million to $105 million.
The company's shares closed at $1.83. A year ago, they were trading at $4.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARLZ at https://www.zacks.com/ap/ARLZ